Limitations, agreements, and source contact

Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support · Source last updated 2012-02-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

restrictive Agreement

false

point Of Contact

email

ytdinh@mdanderson.org

organization

UT MD Anderson Cancer Center

title

Richard E. Champlin/Professor

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice